A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.
From visualising microscopic cells to massive galaxies, imaging is a core tool for many disciplines, and it’s also the basis of a surge in recent technical developments – some of which are being pioneered in Cambridge. Today, we begin a month-long focus on research that is exploring far beyond what the eye can see, introduced here by Stella Panayotova, Stefanie Reichelt and Carola-Bibiane Schönlieb.